InsiderTrades

Form 4 for MET MetLife

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001099219-24-000051 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-29 2024-02-27 MET Khalaf Michel Pres, CEO, Dir A - Grant — +239.3K 418.5K +134% —
D 2024-02-29 2024-02-27 MET Khalaf Michel Pres, CEO, Dir F - Tax $69.16 -113.3K 512.0K -18% -$7.84M
D 2024-02-29 2024-02-27 MET Khalaf Michel Pres, CEO, Dir A - Grant $0.00 +97.6K 97.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-27 A A 206,752 — 625,273 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
2 Common Common Stock 2024-02-27 A A 32,534 — 418,521 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2024-02-27 F D 113,305 $69.16 511,968 D — —
4 Derivative Employee Stock Options (right to buy) 2024-02-27 A A 97,614 $0.00 97,614 D $69.16 · — to 2034-02-26 97,614 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.